| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 14.072 | 43.447 | 57.689 | 68.060 | 99.636 | 103.963 | 150.048 | 175.286 | 132.974 |
| Total Income - EUR | - | 14.074 | 43.451 | 57.708 | 68.094 | 99.702 | 103.984 | 150.073 | 177.501 | 137.564 |
| Total Expenses - EUR | - | 9.745 | 23.658 | 30.140 | 57.519 | 47.135 | 50.946 | 65.500 | 83.035 | 65.274 |
| Gross Profit/Loss - EUR | - | 4.330 | 19.793 | 27.568 | 10.575 | 52.567 | 53.038 | 84.573 | 94.466 | 72.290 |
| Net Profit/Loss - EUR | - | 4.119 | 19.358 | 27.248 | 10.067 | 51.571 | 52.019 | 83.072 | 93.275 | 68.728 |
| Employees | - | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 2 |
Check the financial reports for the company - Neselimed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 704 | 820 | 706 | 612 | 2.983 | 417 |
| Current Assets | - | 4.869 | 27.325 | 49.963 | 60.547 | 56.667 | 52.976 | 86.011 | 136.336 | 206.757 |
| Inventories | - | 212 | 407 | 2.401 | 3.310 | 0 | 0 | 0 | 203 | 0 |
| Receivables | - | 0 | 3.755 | 3.715 | 1.703 | 8.073 | 8.068 | 49.076 | 30.184 | 5.906 |
| Cash | - | 4.657 | 23.164 | 43.847 | 55.534 | 48.594 | 44.908 | 36.935 | 45.300 | 98.442 |
| Shareholders Funds | - | 4.186 | 19.424 | 46.315 | 55.486 | 51.644 | 52.091 | 83.144 | 135.398 | 201.705 |
| Social Capital | - | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | - | 3.113 | 10.290 | 5.992 | 8.065 | 8.099 | 3.797 | 5.691 | 6.126 | 5.468 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neselimed Srl